Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis

BACKGROUND: There is uncertainty and limited data regarding initiation of sodium-glucose cotransporter 2 (SGLT2) inhibitors among patients hospitalized with acute heart failure (AHF). This systematic review and meta-analysis aim to establish the efficacy and safety of SGLT2 inhibitors initiated in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Salah, Husam M., Al’Aref, Subhi J., Khan, Muhammad Shahzeb, Al-Hawwas, Malek, Vallurupalli, Srikanth, Mehta, Jawahar L., Mounsey, J. Paul, Greene, Stephen J., McGuire, Darren K., Lopes, Renato D., Fudim, Marat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817537/
https://www.ncbi.nlm.nih.gov/pubmed/35123480
http://dx.doi.org/10.1186/s12933-022-01455-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817537/
https://www.ncbi.nlm.nih.gov/pubmed/35123480
http://dx.doi.org/10.1186/s12933-022-01455-2

Ejemplares similares